ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anticoagulants Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-18M9167
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Anticoagulants Market Size Status and Forecast 2022
BUY CHAPTERS

Global Anticoagulants Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-18M9167
Report
June 2025
Pages:135
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bristol–Myers Squibb
Bayer
Johnson & Johnson
Genentech (Roche)
Boehringer Ingelheim
Lilly
Daiichi Sankyo
Otsuka
Astrazeneca plc
Pfizer Inc
Aspen
The Medicines Company
Sanofi

Anticoagulants Market Size

In 2024, the global market size of Anticoagulants was estimated to be worth US$ 28430 million and is forecast to reach approximately US$ 39030 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.

Anticoagulants Market

Anticoagulants Market

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares.
North America is the largest consumption place, with a consumption market share nearly 39%. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anticoagulants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticoagulants.
The Anticoagulants market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anticoagulants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anticoagulants companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Anticoagulants Market Report

Report Metric Details
Report Name Anticoagulants Market
CAGR 4.7%
Segment by Type
  • Platelet Aggregation Inhibitors (PAI)
  • Low-Molecular-Weight Heparin (LMWH)
  • Direct Thrombin Inhibitor (DTI)
  • Direct Factor Xa Inhibitors (DFXa)
  • Vitamin K antagonists (VKA)
  • Others
Segment by Application
  • VTE
  • ACS/MI
  • AF
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson., Genentech (Roche), Boehringer Ingelheim, Lilly, Daiichi Sankyo, Otsuka, AstraZeneca, Pfizer, Aspen, The Medicines Company
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Anticoagulants in global and regional level.
  • Chapter 3: Detailed analysis of Anticoagulants company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anticoagulants revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Sanofi, Bristol Myers Squibb, Bayer, Genentech (Roche), Boehringer Ingelheim share in Anticoagulants Market?

Ans: Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares.

What is the Anticoagulants Market share by region?

Ans: North America is the largest consumption place, with a consumption market share nearly 39%.

Who are the main players in the Anticoagulants Market report?

Ans: The main players in the Anticoagulants Market are Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson., Genentech (Roche), Boehringer Ingelheim, Lilly, Daiichi Sankyo, Otsuka, AstraZeneca, Pfizer, Aspen, The Medicines Company

What are the Application segmentation covered in the Anticoagulants Market report?

Ans: The Applications covered in the Anticoagulants Market report are VTE, ACS/MI, AF, Others

What are the Type segmentation covered in the Anticoagulants Market report?

Ans: The Types covered in the Anticoagulants Market report are Platelet Aggregation Inhibitors (PAI), Low-Molecular-Weight Heparin (LMWH), Direct Thrombin Inhibitor (DTI), Direct Factor Xa Inhibitors (DFXa), Vitamin K antagonists (VKA), Others

1 Study Coverage
1.1 Anticoagulants Product Introduction
1.2 Market by Type
1.2.1 Global Anticoagulants Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Platelet Aggregation Inhibitors (PAI)
1.2.3 Low-Molecular-Weight Heparin (LMWH)
1.2.4 Direct Thrombin Inhibitor (DTI)
1.2.5 Direct Factor Xa Inhibitors (DFXa)
1.2.6 Vitamin K antagonists (VKA)
1.2.7 Others
1.3 Market by Application
1.3.1 Global Anticoagulants Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Anticoagulants Market Size Estimates and Forecasts
2.2 Anticoagulants Market Size by Region: 2024 Versus 2031
2.2.1 Global Anticoagulants Revenue by Region: 2020-2025
2.2.2 Global Anticoagulants Revenue Forecast by Region (2026-2031)
2.2.3 Global Anticoagulants Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Anticoagulants Revenue by Type (2020-2031)
3.1.2 Global Anticoagulants Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Anticoagulants Revenue by Application (2020-2031)
3.2.2 Global Anticoagulants Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Platelet Aggregation Inhibitors (PAI) of Anticoagulants Revenue Market Share by Application
3.3.2 Low-Molecular-Weight Heparin (LMWH) of Anticoagulants Revenue Market Share by Application
3.3.3 Direct Thrombin Inhibitor (DTI) of Anticoagulants Revenue Market Share by Application
3.3.4 Direct Factor Xa Inhibitors (DFXa) of Anticoagulants Revenue Market Share by Application
3.3.5 Vitamin K antagonists (VKA) of Anticoagulants Revenue Market Share by Application
3.3.6 Others of Anticoagulants Revenue Market Share by Application
4 Global Anticoagulants by Company
4.1 Global Anticoagulants Revenue by Company (2020-2025)
4.2 Global Anticoagulants Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Anticoagulants Companies around the World: Ranking by Revenue
4.3.2 Global Anticoagulants Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Anticoagulants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Anticoagulants Companies Headquarters & Product Type
4.4.1 Global Anticoagulants Companies Headquarters
4.4.2 Date of International Companies Enter into Anticoagulants Market
4.4.3 Global Anticoagulants Companies Product & Service
4.4.4 Platelet Aggregation Inhibitors (PAI) Revenue Market Share of Anticoagulants by Company
4.4.5 Low-Molecular-Weight Heparin (LMWH) Revenue Market Share of Anticoagulants by Company
4.4.6 Direct Thrombin Inhibitor (DTI) Revenue Market Share of Anticoagulants by Company
4.4.7 Direct Factor Xa Inhibitors (DFXa) Revenue Market Share of Anticoagulants by Company
4.4.8 Vitamin K antagonists (VKA) Revenue Market Share of Anticoagulants by Company
4.4.9 Others Revenue Market Share of Anticoagulants by Company
4.5 Global Anticoagulants Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Sanofi
5.1.1 Sanofi Corporation Information
5.1.2 Sanofi Description, Business Overview
5.1.3 Sanofi Anticoagulants Products Offered
5.1.4 Sanofi Anticoagulants Revenue and Gross Margin (2020-2025)
5.1.5 Sanofi Anticoagulants Revenue by Product in 2024
5.1.6 Sanofi Anticoagulants Revenue by Application in 2024
5.1.7 Sanofi Anticoagulants Revenue by Geographic Area in 2024
5.1.8 Sanofi Recent Developments
5.2 Bristol-Myers Squibb
5.2.1 Bristol-Myers Squibb Corporation Information
5.2.2 Bristol-Myers Squibb Description, Business Overview
5.2.3 Bristol-Myers Squibb Anticoagulants Products Offered
5.2.4 Bristol-Myers Squibb Anticoagulants Revenue and Gross Margin (2020-2025)
5.2.5 Bristol-Myers Squibb Anticoagulants Revenue by Product in 2024
5.2.6 Bristol-Myers Squibb Anticoagulants Revenue by Application in 2024
5.2.7 Bristol-Myers Squibb Anticoagulants Revenue by Geographic Area in 2024
5.2.8 Bristol-Myers Squibb Recent Developments
5.3 Bayer
5.3.1 Bayer Corporation Information
5.3.2 Bayer Description, Business Overview
5.3.3 Bayer Anticoagulants Products Offered
5.3.4 Bayer Anticoagulants Revenue and Gross Margin (2020-2025)
5.3.5 Bayer Anticoagulants Revenue by Product in 2024
5.3.6 Bayer Anticoagulants Revenue by Application in 2024
5.3.7 Bayer Anticoagulants Revenue by Geographic Area in 2024
5.3.8 Bayer Recent Developments
5.4 Johnson & Johnson.
5.4.1 Johnson & Johnson. Corporation Information
5.4.2 Johnson & Johnson. Description, Business Overview
5.4.3 Johnson & Johnson. Anticoagulants Products Offered
5.4.4 Johnson & Johnson. Anticoagulants Revenue and Gross Margin (2020-2025)
5.4.5 Johnson & Johnson. Anticoagulants Revenue by Product in 2024
5.4.6 Johnson & Johnson. Anticoagulants Revenue by Application in 2024
5.4.7 Johnson & Johnson. Anticoagulants Revenue by Geographic Area in 2024
5.4.8 Johnson & Johnson. Recent Developments
5.5 Genentech (Roche)
5.5.1 Genentech (Roche) Corporation Information
5.5.2 Genentech (Roche) Description, Business Overview
5.5.3 Genentech (Roche) Anticoagulants Products Offered
5.5.4 Genentech (Roche) Anticoagulants Revenue and Gross Margin (2020-2025)
5.5.5 Genentech (Roche) Anticoagulants Revenue by Product in 2024
5.5.6 Genentech (Roche) Anticoagulants Revenue by Application in 2024
5.5.7 Genentech (Roche) Anticoagulants Revenue by Geographic Area in 2024
5.5.8 Genentech (Roche) Recent Developments
5.6 Boehringer Ingelheim
5.6.1 Boehringer Ingelheim Corporation Information
5.6.2 Boehringer Ingelheim Description, Business Overview
5.6.3 Boehringer Ingelheim Anticoagulants Products Offered
5.6.4 Boehringer Ingelheim Anticoagulants Revenue and Gross Margin (2020-2025)
5.6.5 Boehringer Ingelheim Anticoagulants Revenue by Product in 2024
5.6.6 Boehringer Ingelheim Anticoagulants Revenue by Application in 2024
5.6.7 Boehringer Ingelheim Anticoagulants Revenue by Geographic Area in 2024
5.6.8 Boehringer Ingelheim Recent Developments
5.7 Lilly
5.7.1 Lilly Corporation Information
5.7.2 Lilly Description, Business Overview
5.7.3 Lilly Anticoagulants Products Offered
5.7.4 Lilly Anticoagulants Revenue and Gross Margin (2020-2025)
5.7.5 Lilly Anticoagulants Revenue by Product in 2024
5.7.6 Lilly Anticoagulants Revenue by Application in 2024
5.7.7 Lilly Anticoagulants Revenue by Geographic Area in 2024
5.7.8 Lilly Recent Developments
5.8 Daiichi Sankyo
5.8.1 Daiichi Sankyo Corporation Information
5.8.2 Daiichi Sankyo Description, Business Overview
5.8.3 Daiichi Sankyo Anticoagulants Products Offered
5.8.4 Daiichi Sankyo Anticoagulants Revenue and Gross Margin (2020-2025)
5.8.5 Daiichi Sankyo Anticoagulants Revenue by Product in 2024
5.8.6 Daiichi Sankyo Anticoagulants Revenue by Application in 2024
5.8.7 Daiichi Sankyo Anticoagulants Revenue by Geographic Area in 2024
5.8.8 Daiichi Sankyo Recent Developments
5.9 Otsuka
5.9.1 Otsuka Corporation Information
5.9.2 Otsuka Description, Business Overview
5.9.3 Otsuka Anticoagulants Products Offered
5.9.4 Otsuka Anticoagulants Revenue and Gross Margin (2020-2025)
5.9.5 Otsuka Anticoagulants Revenue by Product in 2024
5.9.6 Otsuka Anticoagulants Revenue by Application in 2024
5.9.7 Otsuka Anticoagulants Revenue by Geographic Area in 2024
5.9.8 Otsuka Recent Developments
5.10 AstraZeneca
5.10.1 AstraZeneca Corporation Information
5.10.2 AstraZeneca Description, Business Overview
5.10.3 AstraZeneca Anticoagulants Products Offered
5.10.4 AstraZeneca Anticoagulants Revenue and Gross Margin (2020-2025)
5.10.5 AstraZeneca Anticoagulants Revenue by Product in 2024
5.10.6 AstraZeneca Anticoagulants Revenue by Application in 2024
5.10.7 AstraZeneca Anticoagulants Revenue by Geographic Area in 2024
5.10.8 AstraZeneca Recent Developments
5.11 Pfizer
5.11.1 Pfizer Corporation Information
5.11.2 Pfizer Description, Business Overview
5.11.3 Pfizer Anticoagulants Products Offered
5.11.4 Pfizer Anticoagulants Revenue and Gross Margin (2020-2025)
5.11.5 Pfizer Anticoagulants Revenue by Product in 2024
5.11.6 Pfizer Anticoagulants Revenue by Application in 2024
5.11.7 Pfizer Anticoagulants Revenue by Geographic Area in 2024
5.11.8 Pfizer Recent Developments
5.12 Aspen
5.12.1 Aspen Corporation Information
5.12.2 Aspen Description, Business Overview
5.12.3 Aspen Anticoagulants Products Offered
5.12.4 Aspen Anticoagulants Revenue and Gross Margin (2020-2025)
5.12.5 Aspen Anticoagulants Revenue by Product in 2024
5.12.6 Aspen Anticoagulants Revenue by Application in 2024
5.12.7 Aspen Anticoagulants Revenue by Geographic Area in 2024
5.12.8 Aspen Recent Developments
5.13 The Medicines Company
5.13.1 The Medicines Company Corporation Information
5.13.2 The Medicines Company Description, Business Overview
5.13.3 The Medicines Company Anticoagulants Products Offered
5.13.4 The Medicines Company Anticoagulants Revenue and Gross Margin (2020-2025)
5.13.5 The Medicines Company Anticoagulants Revenue by Product in 2024
5.13.6 The Medicines Company Anticoagulants Revenue by Application in 2024
5.13.7 The Medicines Company Anticoagulants Revenue by Geographic Area in 2024
5.13.8 The Medicines Company Recent Developments
6 North America
6.1 North America Anticoagulants Market Size YoY Growth 2020-2031
6.2 North America Anticoagulants Market Facts & Figures by Country (2020-2031)
6.3 North America Anticoagulants Revenue by Type (2020-2025)
6.4 North America Anticoagulants Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Anticoagulants Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Anticoagulants Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Anticoagulants Revenue by Type (2020-2025)
7.4 Asia-Pacific Anticoagulants Revenue by Application (2020-2025)
8 Europe
8.1 Europe Anticoagulants Market Size YoY Growth 2020-2031
8.2 Europe Anticoagulants Market Facts & Figures by Country (2020-2031)
8.3 Europe Anticoagulants Revenue by Type (2020-2025)
8.4 Europe Anticoagulants Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Anticoagulants Market Size YoY Growth 2020-2031
9.2 Latin America Anticoagulants Market Facts & Figures by Country (2020-2031)
9.3 Latin America Anticoagulants Revenue by Type (2020-2025)
9.4 Latin America Anticoagulants Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Anticoagulants Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Anticoagulants Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Anticoagulants Revenue by Type (2020-2025)
10.4 Middle East and Africa Anticoagulants Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Anticoagulants Supply Chain Analysis
11.2 Anticoagulants Key Raw Materials and Upstream Suppliers
11.3 Anticoagulants Clients Analysis
11.4 Anticoagulants Sales Channel and Sales Model Analysis
11.4.1 Anticoagulants Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Anticoagulants Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Anticoagulants Distributors
12 Anticoagulants Market Dynamics
12.1 Anticoagulants Industry Trends
12.2 Anticoagulants Market Drivers
12.3 Anticoagulants Market Challenges
12.4 Anticoagulants Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Bristol–Myers Squibb
Bayer
Johnson & Johnson
Genentech (Roche)
Boehringer Ingelheim
Lilly
Daiichi Sankyo
Otsuka
Astrazeneca plc
Pfizer Inc
Aspen
The Medicines Company
Sanofi
List of Tables
 Table 1. Global Anticoagulants Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Anticoagulants Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Anticoagulants Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Anticoagulants Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Anticoagulants Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Anticoagulants Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Anticoagulants Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Anticoagulants Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Anticoagulants Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Anticoagulants Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Anticoagulants Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Anticoagulants Players by Revenue (US$ Million) in 2024
 Table 13. Global Anticoagulants Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Anticoagulants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticoagulants as of 2024)
 Table 15. Global Anticoagulants Companies Headquarters
 Table 16. Date of International Companies Enter into Anticoagulants Market
 Table 17. Global Anticoagulants Companies Product & Service
 Table 18. Global Anticoagulants Mergers & Acquisitions, Expansion Plans
 Table 19. Sanofi Corporation Information
 Table 20. Sanofi Description and Business Overview
 Table 21. Sanofi Anticoagulants Product
 Table 22. Sanofi Anticoagulants Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Sanofi Revenue Proportion of Anticoagulants by Product in 2024
 Table 24. Sanofi Revenue Proportion of Anticoagulants by Application in 2024
 Table 25. Sanofi Revenue Proportion of Anticoagulants by Geographic Area in 2024
 Table 26. Sanofi Recent Developments
 Table 27. Bristol-Myers Squibb Corporation Information
 Table 28. Bristol-Myers Squibb Description and Business Overview
 Table 29. Bristol-Myers Squibb Anticoagulants Product
 Table 30. Bristol-Myers Squibb Anticoagulants Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Bristol-Myers Squibb Revenue Proportion of Anticoagulants by Product in 2024
 Table 32. Bristol-Myers Squibb Revenue Proportion of Anticoagulants by Application in 2024
 Table 33. Bristol-Myers Squibb Revenue Proportion of Anticoagulants by Geographic Area in 2024
 Table 34. Bristol-Myers Squibb Recent Developments
 Table 35. Bayer Corporation Information
 Table 36. Bayer Description and Business Overview
 Table 37. Bayer Anticoagulants Product
 Table 38. Bayer Anticoagulants Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Bayer Revenue Proportion of Anticoagulants by Product in 2024
 Table 40. Bayer Revenue Proportion of Anticoagulants by Application in 2024
 Table 41. Bayer Revenue Proportion of Anticoagulants by Geographic Area in 2024
 Table 42. Bayer Recent Developments
 Table 43. Johnson & Johnson. Corporation Information
 Table 44. Johnson & Johnson. Description and Business Overview
 Table 45. Johnson & Johnson. Anticoagulants Product
 Table 46. Johnson & Johnson. Anticoagulants Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Johnson & Johnson. Revenue Proportion of Anticoagulants by Product in 2024
 Table 48. Johnson & Johnson. Revenue Proportion of Anticoagulants by Application in 2024
 Table 49. Johnson & Johnson. Revenue Proportion of Anticoagulants by Geographic Area in 2024
 Table 50. Johnson & Johnson. Recent Developments
 Table 51. Genentech (Roche) Corporation Information
 Table 52. Genentech (Roche) Description and Business Overview
 Table 53. Genentech (Roche) Anticoagulants Product
 Table 54. Genentech (Roche) Anticoagulants Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Genentech (Roche) Revenue Proportion of Anticoagulants by Product in 2024
 Table 56. Genentech (Roche) Revenue Proportion of Anticoagulants by Application in 2024
 Table 57. Genentech (Roche) Revenue Proportion of Anticoagulants by Geographic Area in 2024
 Table 58. Genentech (Roche) Recent Developments
 Table 59. Boehringer Ingelheim Corporation Information
 Table 60. Boehringer Ingelheim Description and Business Overview
 Table 61. Boehringer Ingelheim Anticoagulants Product
 Table 62. Boehringer Ingelheim Anticoagulants Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. Boehringer Ingelheim Revenue Proportion of Anticoagulants by Product in 2024
 Table 64. Boehringer Ingelheim Revenue Proportion of Anticoagulants by Application in 2024
 Table 65. Boehringer Ingelheim Revenue Proportion of Anticoagulants by Geographic Area in 2024
 Table 66. Boehringer Ingelheim Recent Developments
 Table 67. Lilly Corporation Information
 Table 68. Lilly Description and Business Overview
 Table 69. Lilly Anticoagulants Product
 Table 70. Lilly Anticoagulants Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. Lilly Revenue Proportion of Anticoagulants by Product in 2024
 Table 72. Lilly Revenue Proportion of Anticoagulants by Application in 2024
 Table 73. Lilly Revenue Proportion of Anticoagulants by Geographic Area in 2024
 Table 74. Lilly Recent Developments
 Table 75. Daiichi Sankyo Corporation Information
 Table 76. Daiichi Sankyo Description and Business Overview
 Table 77. Daiichi Sankyo Anticoagulants Product
 Table 78. Daiichi Sankyo Anticoagulants Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. Daiichi Sankyo Revenue Proportion of Anticoagulants by Product in 2024
 Table 80. Daiichi Sankyo Revenue Proportion of Anticoagulants by Application in 2024
 Table 81. Daiichi Sankyo Revenue Proportion of Anticoagulants by Geographic Area in 2024
 Table 82. Daiichi Sankyo Recent Developments
 Table 83. Otsuka Corporation Information
 Table 84. Otsuka Description and Business Overview
 Table 85. Otsuka Anticoagulants Product
 Table 86. Otsuka Anticoagulants Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. Otsuka Revenue Proportion of Anticoagulants by Product in 2024
 Table 88. Otsuka Revenue Proportion of Anticoagulants by Application in 2024
 Table 89. Otsuka Revenue Proportion of Anticoagulants by Geographic Area in 2024
 Table 90. Otsuka Recent Developments
 Table 91. AstraZeneca Corporation Information
 Table 92. AstraZeneca Description and Business Overview
 Table 93. AstraZeneca Anticoagulants Product
 Table 94. AstraZeneca Anticoagulants Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. AstraZeneca Revenue Proportion of Anticoagulants by Product in 2024
 Table 96. AstraZeneca Revenue Proportion of Anticoagulants by Application in 2024
 Table 97. AstraZeneca Revenue Proportion of Anticoagulants by Geographic Area in 2024
 Table 98. AstraZeneca Recent Developments
 Table 99. Pfizer Corporation Information
 Table 100. Pfizer Description and Business Overview
 Table 101. Pfizer Anticoagulants Product
 Table 102. Pfizer Anticoagulants Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Pfizer Revenue Proportion of Anticoagulants by Product in 2024
 Table 104. Pfizer Revenue Proportion of Anticoagulants by Application in 2024
 Table 105. Pfizer Revenue Proportion of Anticoagulants by Geographic Area in 2024
 Table 106. Pfizer Recent Developments
 Table 107. Aspen Corporation Information
 Table 108. Aspen Description and Business Overview
 Table 109. Aspen Anticoagulants Product
 Table 110. Aspen Anticoagulants Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 111. Aspen Revenue Proportion of Anticoagulants by Product in 2024
 Table 112. Aspen Revenue Proportion of Anticoagulants by Application in 2024
 Table 113. Aspen Revenue Proportion of Anticoagulants by Geographic Area in 2024
 Table 114. Aspen Recent Developments
 Table 115. The Medicines Company Corporation Information
 Table 116. The Medicines Company Description and Business Overview
 Table 117. The Medicines Company Anticoagulants Product
 Table 118. The Medicines Company Anticoagulants Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 119. The Medicines Company Revenue Proportion of Anticoagulants by Product in 2024
 Table 120. The Medicines Company Revenue Proportion of Anticoagulants by Application in 2024
 Table 121. The Medicines Company Revenue Proportion of Anticoagulants by Geographic Area in 2024
 Table 122. The Medicines Company Recent Developments
 Table 123. North America Anticoagulants Revenue by Country (2020-2025) & (US$ Million)
 Table 124. North America Anticoagulants Revenue by Country (2026-2031) & (US$ Million)
 Table 125. North America Anticoagulants Revenue by Type (2020-2025) & (US$ Million)
 Table 126. North America Anticoagulants Revenue by Application (2020-2025) & (US$ Million)
 Table 127. Asia-Pacific Anticoagulants Revenue by Region (2020-2025) & (US$ Million)
 Table 128. Asia-Pacific Anticoagulants Revenue by Region (2026-2031) & (US$ Million)
 Table 129. Asia-Pacific Anticoagulants Revenue by Type (2020-2025) & (US$ Million)
 Table 130. Asia-Pacific Anticoagulants Revenue by Application (2020-2025) & (US$ Million)
 Table 131. Europe Anticoagulants Revenue by Country (2020-2025) & (US$ Million)
 Table 132. Europe Anticoagulants Revenue by Country (2026-2031) & (US$ Million)
 Table 133. Europe Anticoagulants Revenue by Type (2020-2025) & (US$ Million)
 Table 134. Europe Anticoagulants Revenue by Application (2020-2025) & (US$ Million)
 Table 135. Latin America Anticoagulants Revenue by Country (2020-2025) & (US$ Million)
 Table 136. Latin America Anticoagulants Revenue by Country (2026-2031) & (US$ Million)
 Table 137. Latin America Anticoagulants Revenue by Type (2020-2025) & (US$ Million)
 Table 138. Latin America Anticoagulants Revenue by Application (2020-2025) & (US$ Million)
 Table 139. Middle East and Africa Anticoagulants Revenue by Country (2020-2025) & (US$ Million)
 Table 140. Middle East and Africa Anticoagulants Revenue by Country (2026-2031) & (US$ Million)
 Table 141. Middle East and Africa Anticoagulants Revenue by Type (2020-2025) & (US$ Million)
 Table 142. Middle East and Africa Anticoagulants Revenue by Application (2020-2025) & (US$ Million)
 Table 143. Anticoagulants Key Raw Materials, Industry Status and Trend
 Table 144. Anticoagulants Key Raw Materials and Upstream Suppliers
 Table 145. Anticoagulants Clients Status and Trend
 Table 146. Anticoagulants Typical Clients
 Table 147. Anticoagulants Distributors
 Table 148. Anticoagulants Market Trends
 Table 149. Anticoagulants Market Drivers
 Table 150. Anticoagulants Market Challenges
 Table 151. Anticoagulants Market Restraints
 Table 152. Research Programs/Design for This Report
 Table 153. Key Data Information from Secondary Sources
 Table 154. Key Data Information from Primary Sources


List of Figures
 Figure 1. Anticoagulants Product Picture
 Figure 2. Global Anticoagulants Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Anticoagulants Revenue Market Share by Type in 2024 & 2031
 Figure 4. Platelet Aggregation Inhibitors (PAI) Product Picture
 Figure 5. Low-Molecular-Weight Heparin (LMWH) Product Picture
 Figure 6. Direct Thrombin Inhibitor (DTI) Product Picture
 Figure 7. Direct Factor Xa Inhibitors (DFXa) Product Picture
 Figure 8. Vitamin K antagonists (VKA) Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Anticoagulants Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 11. Global Anticoagulants Revenue Market Share by Application in 2024 & 2031
 Figure 12. VTE
 Figure 13. ACS/MI
 Figure 14. AF
 Figure 15. Others
 Figure 16. Anticoagulants Report Years Considered
 Figure 17. Global Anticoagulants Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Anticoagulants Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Anticoagulants Market Size Market Share by Region: 2024 Versus 2031
 Figure 20. Global Anticoagulants Revenue Market Share by Region (2020-2031)
 Figure 21. Global Anticoagulants Revenue Market Share Forecast by Type (2020-2031)
 Figure 22. Global Anticoagulants Revenue Market Share Forecast by Application (2020-2031)
 Figure 23. Platelet Aggregation Inhibitors (PAI) of Anticoagulants Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Low-Molecular-Weight Heparin (LMWH) of Anticoagulants Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Direct Thrombin Inhibitor (DTI) of Anticoagulants Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Direct Factor Xa Inhibitors (DFXa) of Anticoagulants Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Vitamin K antagonists (VKA) of Anticoagulants Revenue Market Share by Application, 2024 VS 2031
 Figure 28. Others of Anticoagulants Revenue Market Share by Application, 2024 VS 2031
 Figure 29. Anticoagulants Revenue Share by Company (2024)
 Figure 30. Anticoagulants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 31. Platelet Aggregation Inhibitors (PAI) Revenue Proportion by Company in 2024
 Figure 32. Low-Molecular-Weight Heparin (LMWH) Revenue Proportion by Company in 2024
 Figure 33. Direct Thrombin Inhibitor (DTI) Revenue Proportion by Company in 2024
 Figure 34. Direct Factor Xa Inhibitors (DFXa) Revenue Proportion by Company in 2024
 Figure 35. Vitamin K antagonists (VKA) Revenue Proportion by Company in 2024
 Figure 36. Others Revenue Proportion by Company in 2024
 Figure 37. North America Anticoagulants Revenue 2020-2031 (US$ Million)
 Figure 38. North America Anticoagulants Revenue Market Share by Type (2020-2025)
 Figure 39. North America Anticoagulants Revenue Market Share by Application (2020-2025)
 Figure 40. Asia-Pacific Anticoagulants Revenue 2020-2031 (US$ Million)
 Figure 41. Asia-Pacific Anticoagulants Revenue Market Share by Region (2020-2031)
 Figure 42. Asia-Pacific Anticoagulants Revenue Market Share by Type (2020-2025)
 Figure 43. Asia-Pacific Anticoagulants Revenue Market Share by Application (2020-2025)
 Figure 44. Europe Anticoagulants Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 45. Europe Anticoagulants Revenue Market Share by Country (2020-2031)
 Figure 46. Europe Anticoagulants Revenue Market Share by Type (2020-2025)
 Figure 47. Europe Anticoagulants Revenue Market Share by Application (2020-2025)
 Figure 48. Latin America Anticoagulants Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 49. Latin America Anticoagulants Revenue Market Share by Country (2020-2031)
 Figure 50. Latin America Anticoagulants Revenue Market Share by Type (2020-2025)
 Figure 51. Latin America Anticoagulants Revenue Market Share by Application (2020-2025)
 Figure 52. Middle East and Africa Anticoagulants Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 53. Middle East and Africa Anticoagulants Revenue Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Anticoagulants Revenue Market Share by Type (2020-2025)
 Figure 55. Middle East and Africa Anticoagulants Revenue Market Share by Application (2020-2025)
 Figure 56. Anticoagulants Supply Chain (Upstream and Downstream Market)
 Figure 57. Global Production Market Share of Anticoagulants Raw Materials by Region in 2024
 Figure 58. Anticoagulants Distribution Channels
 Figure 59. Global Anticoagulants Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 60. Global Anticoagulants Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Heparin Anticoagulant Market Insights Forecast to 2028
Global Oral Anticoagulants Market Research Report 2024
Global Direct Oral Anticoagulant Market Insights Forecast to 2030
Global Anticoagulant Drugs Market Insights Forecast to 2030
Global Injectable Blood Thinners Market Research Report 2025
Global Novel Oral Anticoagulants Drugs Market Insights Forecast to 2030
Global Anticoagulant Treatment Market Insights Forecast to 2030
Global Anticoagulant Reversal Agent Market Research Report 2024
Global Anticoagulant Medicines Market Research Report 2025
Global Anticoagulation Tube Market Research Report 2025
Global Intravenous Anticoagulants Market Research Report 2024
Sodium Heparin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anticoagulants for Hemodialysis Market Research Report 2024
Global Hemodialysis Anticoagulant Treatment Drugs Market Research Report 2024
Global Heparin Market Insights Forecast to 2030
Global Enoxaparin Sodium Market Research Report 2024
Global Heparin Sodium Market Insights Forecast to 2030
Global Oral Factor Xa Inhibitors Market Research Report 2024
Global Anticoagulant and Non Anticoagulant Rodenticides Market Research Report 2024
Global Factor Xa Inhibitors Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions